Search Results

There are 4678 results for: content related to: Brain activity and emotional processing in smokers treated with varenicline

  1. You have free access to this content
    Nicotine receptor partial agonists for smoking cessation

    Intervention Review

    The Cochrane Library

    Kate Cahill, Lindsay F Stead and Tim Lancaster

    Published Online : 18 APR 2012, DOI: 10.1002/14651858.CD006103.pub6

  2. The effect of varenicline on the development and expression of nicotine-induced behavioral sensitization and cross-sensitization in rats

    Addiction Biology

    Wouter Goutier, Margreet B. Kloeze and Andrew C. McCreary

    Article first published online : 20 NOV 2013, DOI: 10.1111/adb.12108

  3. You have full text access to this OnlineOpen article
    Varenicline decreases ethanol intake and increases dopamine release via neuronal nicotinic acetylcholine receptors in the nucleus accumbens

    British Journal of Pharmacology

    Volume 171, Issue 14, July 2014, Pages: 3420–3431, A A Feduccia, J A Simms, D Mill, H Y Yi and S E Bartlett

    Article first published online : 25 JUN 2014, DOI: 10.1111/bph.12690

  4. You have free access to this content
    Pharmacological interventions for smoking cessation: an overview and network meta-analysis

    Overview of Reviews

    The Cochrane Library

    Kate Cahill, Sarah Stevens, Rafael Perera and Tim Lancaster

    Published Online : 31 MAY 2013, DOI: 10.1002/14651858.CD009329.pub2

  5. Multiple-Dose Pharmacokinetics of the Selective Nicotinic Receptor Partial Agonist, Varenicline, in Healthy Smokers

    The Journal of Clinical Pharmacology

    Volume 46, Issue 12, December 2006, Pages: 1439–1448, Dr Hélène M. Faessel, Dr Megan A. Gibbs, Dr David J. Clark, Mr Kevin Rohrbacher, Dr Marilyn Stolar and Dr Aaron H. Burstein

    Article first published online : 8 MAR 2013, DOI: 10.1177/0091270006292624

  6. Single-Dose Pharmacokinetics of Varenicline, a Selective Nicotinic Receptor Partial Agonist, in Healthy Smokers and Nonsmokers

    The Journal of Clinical Pharmacology

    Volume 46, Issue 9, September 2006, Pages: 991–998, Dr Hélène M. Faessel, Dr Bill J. Smith, Dr Megan A. Gibbs, Dr Jason S. Gobey, Dr David J. Clark and Dr Aaron H. Burstein

    Article first published online : 8 MAR 2013, DOI: 10.1177/0091270006290669

  7. Exposure to the smoking cessation medicine varenicline during pregnancy: a prospective nationwide cohort study

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 10, October 2013, Pages: 1086–1092, Mira Harrison-Woolrych, Helen Paterson and Ming Tan

    Article first published online : 8 AUG 2013, DOI: 10.1002/pds.3489

  8. Lack of Pharmacokinetic and Pharmacodynamic Interactions Between a Smoking Cessation Therapy, Varenicline, and Warfarin: An In Vivo and In Vitro Study

    The Journal of Clinical Pharmacology

    Volume 47, Issue 11, November 2007, Pages: 1421–1429, Dr Aaron H. Burstein, Dr David J. Clark, Ms Melissa O'Gorman, Dr Susan A. Willavize, Mr Timothy G. Brayman, Mr G. Scott Grover, Mr Robert L. Walsky, Dr R. Scott Obach and Dr Hélène M. Faessel

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270007307574

  9. Varenicline efficacy and safety among methadone maintained smokers: a randomized placebo-controlled trial

    Addiction

    Volume 109, Issue 9, September 2014, Pages: 1554–1563, Shadi Nahvi, Yuming Ning, Kate S. Segal, Kimber P. Richter and Julia H. Arnsten

    Article first published online : 27 JUN 2014, DOI: 10.1111/add.12631

  10. A review of cost-effectiveness of varenicline and comparison of cost-effectiveness of treatments for major smoking-related morbidities

    Journal of Evaluation in Clinical Practice

    Volume 17, Issue 2, April 2011, Pages: 288–297, Evelina A. Zimovetz, Koo Wilson, Miny Samuel and Stephen M. Beard

    Article first published online : 4 OCT 2010, DOI: 10.1111/j.1365-2753.2010.01439.x

  11. The Nicotinic Acetylcholine Receptor Partial Agonist Varenicline Increases the Ataxic and Sedative-Hypnotic Effects of Acute Ethanol Administration in C57BL/6J Mice

    Alcoholism: Clinical and Experimental Research

    Volume 34, Issue 12, December 2010, Pages: 2053–2060, Helen M. Kamens, Jimena Andersen and Marina R. Picciotto

    Article first published online : 14 OCT 2010, DOI: 10.1111/j.1530-0277.2010.01301.x

  12. Varenicline in the routine treatment of tobacco dependence: a pre–post comparison with nicotine replacement therapy and an evaluation in those with mental illness

    Addiction

    Volume 103, Issue 1, January 2008, Pages: 146–154, John A. Stapleton, Lucy Watson, Lucy I. Spirling, Robert Smith, Andrea Milbrandt, Marina Ratcliffe and Gay Sutherland

    Article first published online : 19 NOV 2007, DOI: 10.1111/j.1360-0443.2007.02083.x

  13. Pharmacokinetics, Safety, and Tolerability After Single and Multiple Oral Doses of Varenicline in Elderly Smokers

    The Journal of Clinical Pharmacology

    Volume 46, Issue 11, November 2006, Pages: 1234–1240, Dr Aaron H. Burstein, Dr Terence Fullerton, Dr David J. Clark and Dr Hélène M. Faessel

    Article first published online : 8 MAR 2013, DOI: 10.1177/0091270006291837

  14. Fifty-two-week continuous abstinence rates of smokers being treated with varenicline versus nicotine replacement therapy

    Addiction

    Volume 108, Issue 8, August 2013, Pages: 1497–1502, Eva Kralikova, Alexandra Kmetova, Lenka Stepankova, Kamila Zvolska, Rachel Davis and Robert West

    Article first published online : 13 MAY 2013, DOI: 10.1111/add.12219

  15. Pharmacokinetics, Safety, and Tolerability Following Multiple Oral Doses of Varenicline Under Various Titration Schedules in Elderly Nonsmokers

    The Journal of Clinical Pharmacology

    Volume 51, Issue 4, April 2011, Pages: 492–501, Dr Qinying Zhao, Dr Elias Schwam, Dr Terence Fullerton, Ms Melissa O'Gorman and Dr Aaron H. Burstein

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270010370461

  16. The Safety and Efficacy of Varenicline in Cocaine Using Smokers Maintained on Methadone: A Pilot Study

    The American Journal on Addictions

    Volume 19, Issue 5, September-October 2010, Pages: 401–408, James Poling, Bruce Rounsaville, Kishorchandra Gonsai, Kevin Severino and Mehmet Sofuoglu

    Article first published online : 2 AUG 2010, DOI: 10.1111/j.1521-0391.2010.00066.x

  17. Varenicline and neuronal nicotinic acetylcholine receptors: A new approach to the treatment of co-occurring alcohol and nicotine addiction?

    The American Journal on Addictions

    Volume 22, Issue 5, SeptemberߝOctober 2013, Pages: 453–459, Roberto Nocente, Mario Vitali, Giuseppe Balducci, Domenico Enea, Henry R. Kranzler and Mauro Ceccanti

    Article first published online : 15 MAY 2013, DOI: 10.1111/j.1521-0391.2013.12037.x

  18. The effectiveness of varenicline medication guide for conveying safety information to patients: a REMS assessment survey

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 7, July 2013, Pages: 705–715, Cheryl Enger, Muhammad Younus, Kenneth R. Petronis, Jingping Mo, Robert Gately and John D. Seeger

    Article first published online : 24 JAN 2013, DOI: 10.1002/pds.3400

  19. Use of the Patient Health Questionnaire-2 to Predict Suicidal Ideations in Patients Taking Varenicline

    The American Journal on Addictions

    Volume 21, Issue 4, July/August 2012, Pages: 356–362, Christopher M. Cowan, Jennifer S. Wink and Kent J. DeZee

    Article first published online : 16 MAY 2012, DOI: 10.1111/j.1521-0391.2012.00243.x

  20. Single- and Multiple-Dose Pharmacokinetics of the Selective Nicotinic Receptor Partial Agonist, Varenicline, in Healthy Japanese Adult Smokers

    The Journal of Clinical Pharmacology

    Volume 51, Issue 4, April 2011, Pages: 527–537, Dr H. Kikkawa, Dr N. Maruyama, Dr Y. Fujimoto and Dr T. Hasunuma

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270010372388